Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| KNSA |
| Kiniksa Pharmaceuticals… |
| MEXER |
| 2,694 |
| — |
| — |
| +18.3% |
| Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER◆ | 1,846 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER◆ | 1,591 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER◆ | 1,750 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 15,600 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 7,800 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 31,150 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | FTAX | 2,510 | $48.13 | $120.8K | -14.5% | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER | 5,187 | — | — | +42.9% | Open the original filing on SEC.gov |